Soluble tumor necrosis factor-like weak inducer of apoptosis overexpression in HEK293 cells promotes tumor growth and angiogenesis in athymic nude mice

被引:84
作者
Ho, DH
Vu, H
Brown, SAN
Donohue, PJ
Hanscom, HN
Winkles, JA
机构
[1] Univ Maryland, Sch Med, Dept Surg, Rockville, MD 20855 USA
[2] Univ Maryland, Sch Med, Dept Physiol, Rockville, MD 20855 USA
[3] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA
关键词
D O I
10.1158/0008-5472.CAN-04-1879
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) is a member of the tumor necrosis factor superfamily of structurally related cytokines. TWEAK acts on responsive cells via binding to a cell surface receptor named Fn14. Recent studies have demonstrated that TWEAK can stimulate numerous cellular responses including cell proliferation, migration, and proinflammatory molecule production. It has also been reported that TWEAK can stimulate blood vessel formation in the rat cornea angiogenesis assay, but it is presently unknown whether this cytokine could play a role in the pathological angiogenesis associated with human diseases such as cancer, rheumatoid arthritis, and diabetic retinopathy. In the present study we investigated whether TWEAK was expressed in human tumors and whether it could promote tumor growth and angiogenesis in vivo. TWEAK mRNA expression was detected in many tumor types by cDNA array hybridization analysis, and TWEAK protein expression was confirmed in human colon cancer tissue by immunohistochemistry. As an initial approach to address whether TWEAK might act as a tumor angiogenesis factor, we established several human embryonic kidney cell lines that constitutively secrete a soluble TWEAK protein and examined their growth properties in vitro and in vivo. We found that although TWEAK-overexpressing cells do not have a growth advantage in vitro, they form larger and more highly vascularized tumors in athymic mice when compared with control, vector-transfected cells. This result suggests that the TWEAK-Fn14 signaling system may be a potential regulator of human tumorigenesis.
引用
收藏
页码:8968 / 8972
页数:5
相关论文
共 29 条
  • [11] Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
    Ferrara, N
    Hillan, KJ
    Gerber, HP
    Novotny, W
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (05) : 391 - 400
  • [12] Pro-inflammatory effect of TWEAK/Fn14 interaction on human umbilical vein endothelial cells
    Harada, N
    Nakayama, M
    Nakano, H
    Fukuchi, Y
    Yagita, H
    Okumura, K
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 299 (03) : 488 - 493
  • [13] SITE-DIRECTED MUTAGENESIS BY OVERLAP EXTENSION USING THE POLYMERASE CHAIN-REACTION
    HO, SN
    HUNT, HD
    HORTON, RM
    PULLEN, JK
    PEASE, LR
    [J]. GENE, 1989, 77 (01) : 51 - 59
  • [14] TWEAK can induce pro-inflammatory cytokines and matrix metalloproteinase-9 in macrophages
    Kim, SH
    Kang, YJ
    Kim, WJ
    Woo, DK
    Lee, Y
    Kim, DI
    Park, YB
    Kwon, BS
    Park, JE
    Lee, WH
    [J]. CIRCULATION JOURNAL, 2004, 68 (04) : 396 - 399
  • [15] The TNF and TNF receptor superfamilies: Integrating mammalian biology
    Locksley, RM
    Killeen, N
    Lenardo, MJ
    [J]. CELL, 2001, 104 (04) : 487 - 501
  • [16] TWEAK induces angiogenesis and proliferation of endothelial cells
    Lynch, CN
    Wang, YC
    Lund, JK
    Chen, YW
    Leal, JA
    Wiley, SR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (13) : 8455 - 8459
  • [17] Identification of a ligand for the death-domain-containing receptor Apo3
    Marsters, SA
    Sheridan, JP
    Pitti, RM
    Brush, J
    Goddard, A
    Ashkenazi, A
    [J]. CURRENT BIOLOGY, 1998, 8 (09) : 525 - 528
  • [18] The mitogen-inducible Fn14 gene encodes a type I transmembrane protein that modulates fibroblast adhesion and migration
    Meighan-Mantha, RL
    Hsu, DKW
    Guo, Y
    Brown, SAN
    Feng, SLY
    Peifley, KA
    Alberts, GF
    Copeland, NG
    Gilbert, DJ
    Jenkins, NA
    Richards, CM
    Winkles, JA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (46) : 33166 - 33176
  • [19] TWEAK mediates signal transduction and differentiation of RAW264.7 cells in the absence of Fn14/TweakR - Evidence for a second TWEAK receptor
    Polek, TC
    Talpaz, M
    Darnay, BG
    Spivak-Kroizman, T
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (34) : 32317 - 32323
  • [20] An endogenous hybrid mRNA encodes TWE-PRIL, a functional cell surface TWEAK-APRIL fusion protein
    Pradet-Balade, B
    Medema, JP
    López-Fraga, M
    Lozano, JC
    Kolfschoten, GM
    Picard, A
    Martínez, C
    Garcia-Sanz, JA
    Hahne, M
    [J]. EMBO JOURNAL, 2002, 21 (21) : 5711 - 5720